Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03621475 · ClinicalTrials.gov registry record · Phase 1
Novel Arm Restraint in the Intensive Care Unit
A Phase 1 study, sponsored by University of Vermont.
- Completed
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
NCT03621475 is a Phase 1 study that has completed, run by University of Vermont. The registered enrollment target is 8 participants.
The verdict
NCT03621475, a Phase 1 study, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
The goal of this pilot is to evaluate a novel restraint device in 8 older mechanically ventilated patients to demonstrate that 1) the revised novel restraint prototype is safe and 2) a future randomized controlled trial (RCT) is feasible.
Interventions
- DEVICE Novel restraint
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2019-04-15 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03621475
The ClinicalTrials.gov registry entry for NCT03621475 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Novel restraint is the first listed.
NCT03621475 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03621475 about?
NCT03621475 is a clinical study titled "Novel Arm Restraint in the Intensive Care Unit". The goal of this pilot is to evaluate a novel restraint device in 8 older mechanically ventilated patients to demonstrate that 1) the revised novel restraint prototype is safe and 2) a future randomized controlled trial (RCT) is feasible.
What is the current status of trial NCT03621475?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2018-10-01. Estimated completion is 2019-04-15.
What interventions are being tested in trial NCT03621475?
The interventions under investigation include: Novel restraint (DEVICE).
Who is sponsoring clinical trial NCT03621475?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.